These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3858576)

  • 1. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC; Muzyka TG; Fang WD
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
    Warrington RC; Cheng I; Fang WD
    J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
    Edelstein MB; Heilbrun LK
    Cancer Res; 1988 Mar; 48(6):1470-5. PubMed ID: 3345520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
    Warrington RC
    Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
    Stolfi RL; Sawyer RC; Martin DS
    Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved treatment of disseminated B16f10 melanoma in mice with anticancer drugs in combination with L-histidinol.
    Warrington RC; Fang WD
    Anticancer Res; 1991; 11(5):1869-74. PubMed ID: 1722659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs.
    Warrington RC; Cheng I; Zhang L; Fang WD
    Anticancer Res; 1993; 13(6A):2107-12. PubMed ID: 8297120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-histidinol protection against cytotoxic action of cytosine arabinoside and 5-fluorouracil in cultured mouse spleen cells.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1982 Feb; 68(2):279-86. PubMed ID: 6950159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-histidinol on the proliferation and anticancer drug susceptibility of cultured B16f10 melanoma cells.
    Warrington RC; Cheng I; Fang W
    Anticancer Res; 1991; 11(5):1863-7. PubMed ID: 1768057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of L-histidinol and homoharringtonine on 5-fluorouracil and bis-chloroethylnitrosourea activity in a murine model.
    Warrington RC; Fang WD
    Anticancer Res; 1991; 11(5):1879-83. PubMed ID: 1768059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL; Uyeki EM
    J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
    Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of cytosine arabinoside and thiopurines.
    Valeriote F; Vietti T; Edelstein M
    Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lymphoid leukemia colony-forming cells in Abelson virus infected mice: differences in inbred strains.
    Earl CD; Scher CD
    J Cell Physiol; 1980 Aug; 104(2):153-62. PubMed ID: 7410487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infused L-histidinol and cisplatin: schedule, specificity, and proliferation dependence.
    Edelstein MB
    J Natl Cancer Inst; 1989 Feb; 81(4):298-301. PubMed ID: 2913328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
    Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L
    Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.